Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 1 study of SJG-136 in patients with Advanced Leukemia.

Trial Profile

A phase 1 study of SJG-136 in patients with Advanced Leukemia.

Phase of Trial: Phase I

Latest Information Update: 27 Sep 2013

At a glance

  • Drugs SG 2000 (Primary)
  • Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Jul 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 02 Jan 2013 Status changed from completed to recruiting as reported by ClinicalTrials.gov.
    • 07 Jun 2010 Actual patient number (17) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top